163 related articles for article (PubMed ID: 29264528)
21. Nonoral combined hormonal contraceptives and thromboembolism: a systematic review.
Tepper NK; Dragoman MV; Gaffield ME; Curtis KM
Contraception; 2017 Feb; 95(2):130-139. PubMed ID: 27771476
[TBL] [Abstract][Full Text] [Related]
22. The differential risk of oral contraceptives: the impact of full exposure history.
Lewis MA; MacRae KD; Kühl-Habichl D; Bruppacher R; Heinemann LA; Spitzer WO
Hum Reprod; 1999 Jun; 14(6):1493-9. PubMed ID: 10359554
[TBL] [Abstract][Full Text] [Related]
23. Hormonal contraception and thrombosis.
Sitruk-Ware R
Fertil Steril; 2016 Nov; 106(6):1289-1294. PubMed ID: 27678035
[TBL] [Abstract][Full Text] [Related]
24. [Hormonal contraception and risk of venous thromboembolism: When to ask for an assessment of hemostasis? Which parameters?].
Plu-Bureau G; Horellou MH; Gompel A; Conard J
Gynecol Obstet Fertil; 2008 Apr; 36(4):448-54. PubMed ID: 18424163
[TBL] [Abstract][Full Text] [Related]
25. Can a change in screening and prescribing practice reduce the risk of venous thromboembolism in women taking the combined oral contraceptive pill?
Mills A; Wilkinson C; Fotherby K
Br J Fam Plann; 1998 Jan; 23(4):112-5. PubMed ID: 9882763
[TBL] [Abstract][Full Text] [Related]
26. Longitudinal profile of estrogen-related thrombotic biomarkers after cessation of combined hormonal contraceptives.
Hugon-Rodin J; Fontana P; Poncet A; Streuli I; Casini A; Blondon M
Blood; 2024 Jan; 143(1):70-78. PubMed ID: 37939264
[TBL] [Abstract][Full Text] [Related]
27. Incidence of venous thromboembolism in young Swedish women and possibly preventable cases among combined oral contraceptive users.
Samuelsson E; Hägg S
Acta Obstet Gynecol Scand; 2004 Jul; 83(7):674-81. PubMed ID: 15225194
[TBL] [Abstract][Full Text] [Related]
28. Thrombotic diseases in young women and the influence of oral contraceptives.
Lidegaard O
Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 2):S62-7. PubMed ID: 9753312
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for venous thromboembolism in women under combined oral contraceptive. The PILl Genetic RIsk Monitoring (PILGRIM) Study.
Suchon P; Al Frouh F; Henneuse A; Ibrahim M; Brunet D; Barthet MC; Aillaud MF; Venton G; Alessi MC; Trégouët DA; Morange PE
Thromb Haemost; 2016 Jan; 115(1):135-42. PubMed ID: 26290123
[TBL] [Abstract][Full Text] [Related]
30. The risk of venous thromboembolism in users of postcoital contraceptive pills.
Vasilakis C; Jick SS; Jick H
Contraception; 1999 Feb; 59(2):79-83. PubMed ID: 10361621
[TBL] [Abstract][Full Text] [Related]
31. [Hormonal contraception and venous thromboembolism].
Hart C; Linnemann B
Dtsch Med Wochenschr; 2021 Jun; 146(11):705-709. PubMed ID: 34062582
[TBL] [Abstract][Full Text] [Related]
32. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
Schambeck CM; Schwender S; Haubitz I; Geisen UE; Grossmann RE; Keller F
Thromb Haemost; 1997 Dec; 78(6):1480-3. PubMed ID: 9423798
[TBL] [Abstract][Full Text] [Related]
33. Pill, patch or ring? A mixed methods analysis of provider counseling about combined hormonal contraception.
Craig AD; Steinauer J; Kuppermann M; Schmittdiel JA; Dehlendorf C
Contraception; 2019 Feb; 99(2):104-110. PubMed ID: 30227121
[TBL] [Abstract][Full Text] [Related]
34. Selective prescribing of third generation oral contraceptives (OCs).
Jamin C; de Mouzon J
Contraception; 1996 Jul; 54(1):55-6. PubMed ID: 8804809
[TBL] [Abstract][Full Text] [Related]
35. Venous thromboembolism and women's health.
Speed V; Roberts LN; Patel JP; Arya R
Br J Haematol; 2018 Nov; 183(3):346-363. PubMed ID: 30334572
[TBL] [Abstract][Full Text] [Related]
36. Family history of venous thromboembolism is a risk factor for venous thromboembolism in combined oral contraceptive users: a nationwide case-control study.
Zöller B; Ohlsson H; Sundquist J; Sundquist K
Thromb J; 2015; 13():34. PubMed ID: 26500457
[TBL] [Abstract][Full Text] [Related]
37. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.
Wu O; Robertson L; Twaddle S; Lowe GD; Clark P; Greaves M; Walker ID; Langhorne P; Brenkel I; Regan L; Greer I
Health Technol Assess; 2006 Apr; 10(11):1-110. PubMed ID: 16595080
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for fatal venous thromboembolism in young women: a case-control study.
Thorogood M; Mann J; Murphy M; Vessey M
Int J Epidemiol; 1992 Feb; 21(1):48-52. PubMed ID: 1544757
[TBL] [Abstract][Full Text] [Related]
39. Oral contraceptives and venous thromboembolic disease: the findings from database studies in the United Kingdom and Germany.
Farmer RD; Lawrenson RA
Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 2):S78-86. PubMed ID: 9753314
[TBL] [Abstract][Full Text] [Related]
40. Combined hormonal contraception and venous thromboembolism.
Martínez F; Avecilla A
Eur J Contracept Reprod Health Care; 2007 Jun; 12(2):97-106. PubMed ID: 17559006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
